Revision of public health and clinical importance of amoebiasis in Iraq
Natural History Research and Museum Center, University of Baghdad, Iraq.
Review Article
GSC Biological and Pharmaceutical Sciences, 2022, 19(03), 329–333.
Article DOI: 10.30574/gscbps.2022.19.3.0247
Publication history:
Received on 18 May 2022; revised on 26 June 2022; accepted on 28 June 2022
Abstract:
Amebiasis, related to the pathogenic parasite Entamoeba histolytica, is a prominent cause of diarrhea globally. Amebiasis is primarily a disease of impoverished communities in developing nations, although it has recently arisen as a significant infection among returning tourists and immigrants. Severe cases are linked to a high case fatality rate. Although polymerase chain reaction (PCR)-based diagnosis is becoming more widely available, it is still underutilized. Treatment with nitroimidazoles is now suggested, however novel parasite medication research is a top priority. To avoid problems, amebiasis should be considered before corticosteroid therapy. Because there is no effective vaccination, sanitation and availability to clean water are the mainstays of prevention. The article aimed to identify the methods Future tailored therapeutic and previous studies to a better understanding of parasite biology and disease.
Keywords:
Amoebiasis; Entamoeba histolytica; Public Health; Trophozoites; Iraq
Full text article in PDF:
Copyright information:
Copyright © 2022 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0
